CRTAP and osteogenesis imperfecta: Morello R., Bertin T.K., Chen Y., Hicks J., Tonachini L., Monticone M.,Castagnola P., Rauch F., Glorieux F.H., Vranka J., Bachinger H.P.,Pace J.M., Schwarze U., Byers P.H., Weis M.A., Fernandes R.J.,Eyre D.R., Yao Z., Boyce B.F., Lee B. CRTAP is required for prolyl3-hydroxylation and mutations cause recessive osteogenesis imperfecta.Cell.